AI assistant
GlaxoSmithKline PLC — Director's Dealing 2018
Feb 20, 2018
5262_dirs_2018-02-20_aadc8bf6-4353-42ca-bf5a-2de71afdc770.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 4141F
GlaxoSmithKline PLC
20 February 2018
GlaxoSmithKline plc (the 'Company')
Shares sold to meet tax liabilities
Following the vesting of the pre-tax awards granted in 2015 under the GlaxoSmithKline Deferred Annual Bonus Plan ('DABP') on 15 February 2018 and as notified on 16 February 2018, the notifications that follow reflect change in the interests of the Person Discharging Managerial Responsibilities ('PDMRs') in American Depositary Shares ('ADS') of the Company arising from the sale of ADSs to meet tax liabilities.
Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr D E Troy
b)
Position/status
SVP & General Counsel
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
GlaxoSmithKline plc American Depositary Shares ('ADSs')
ISIN: US37733W1053
b)
Nature of the transaction
The sale of ADSs to meet tax liabilities further to the vesting of awards granted in 2015 under the Company's 2009 Deferred Annual Bonus Plan-Deferred Bonus and Matching Awards.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| $37.4803 | 3,480 (Deferred) |
| $37.4803 | 2,520 (Matching) |
d)
Aggregated information
Aggregated volume Price
6,000
$37.4803
e)
Date of the transaction
2018-02-16
f)
Place of the transaction
New York Stock Exchange (XNYS)
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHXBLFLVLFFBBE